Clinical Research Directory
Browse clinical research sites, groups, and studies.
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
Sponsor: Corcept Therapeutics
Summary
This is an open-label extension study to evaluate the long-term safety of relacorilant in patients with endogenous Cushing syndrome who successfully completed participation in a Corcept-sponsored study of relacorilant and may benefit from continuing treatment.
Official title: An Open-Label Extension Study of the Safety of Relacorilant (CORT125134) in the Treatment of the Signs and Symptoms of Endogenous Cushing Syndrome
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
125
Start Date
2018-05-07
Completion Date
2026-12
Last Updated
2026-02-19
Healthy Volunteers
No
Conditions
Interventions
relacorilant
CORT125134 is supplied as capsules for oral dosing.
Locations (48)
Site 49
Phoenix, Arizona, United States
Site 35
Stanford, California, United States
Site 39
Torrance, California, United States
Site 50
Miami, Florida, United States
Site 10
Atlanta, Georgia, United States
Site 9
Chicago, Illinois, United States
Site 1
Indianapolis, Indiana, United States
Site 5
Metairie, Louisiana, United States
Site 27
Baltimore, Maryland, United States
Site 13
Fall River, Massachusetts, United States
Site 8
Ann Arbor, Michigan, United States
Site 36
Rochester, Minnesota, United States
Site 34
Jackson, Mississippi, United States
Site 3
St Louis, Missouri, United States
Site 55
Reno, Nevada, United States
Site 6
Albany, New York, United States
Site 24
New York, New York, United States
Site 4
Wilmington, North Carolina, United States
Site 43
Cleveland, Ohio, United States
Site 2
Pittsburgh, Pennsylvania, United States
Site 46
Pittsburgh, Pennsylvania, United States
Site 11
Dallas, Texas, United States
Site 7
El Paso, Texas, United States
Site 32
Fort Worth, Texas, United States
Site 12
Houston, Texas, United States
Site 14
Vienna, Austria
Site 51
Nova Scotia, Canada
Site 16
Munich, Germany
Site 42
Würzburg, Germany
Site 20
Ramat Gan, Israel
Site 29
Tel Aviv, Israel
Site 40
Ancona, Italy
Site 44
Messina, Italy
Site 25
Milan, Italy
Site 21
Naples, Italy
Site 48
Padova, Italy
Site 52
Torino, Italy
Site 33
Rotterdam, Netherlands
Site 47
Krakow, Poland
Site 45
Lublin, Poland
Site 37
Bucharest, Romania
Site 31
Bucharest, Romania
Site 28
Bucharest, Romania
Site 53
Alicante, Spain
Site 18
Girona, Spain
Site 17
Madrid, Spain
Site 38
Málaga, Spain
Site 19
Seville, Spain